Ritu Ojha

771 total citations
22 papers, 641 citations indexed

About

Ritu Ojha is a scholar working on Organic Chemistry, Molecular Biology and Nephrology. According to data from OpenAlex, Ritu Ojha has authored 22 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Organic Chemistry, 13 papers in Molecular Biology and 4 papers in Nephrology. Recurrent topics in Ritu Ojha's work include Histone Deacetylase Inhibitors Research (6 papers), Quinazolinone synthesis and applications (5 papers) and Synthesis and biological activity (4 papers). Ritu Ojha is often cited by papers focused on Histone Deacetylase Inhibitors Research (6 papers), Quinazolinone synthesis and applications (5 papers) and Synthesis and biological activity (4 papers). Ritu Ojha collaborates with scholars based in India and Taiwan. Ritu Ojha's co-authors include Kunal Nepali, Sahil Sharma, Kunal Nepali, Preet Mohinder Singh Bedi, Harbinder Singh, Kanaya Lal Dhar, Jing‐Ping Liou, Hsueh‐Yun Lee, Manish Gupta and Jagjeet Singh and has published in prestigious journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Ritu Ojha

22 papers receiving 634 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ritu Ojha India 15 372 267 159 94 46 22 641
Samir Mehndiratta Taiwan 17 363 1.0× 384 1.4× 48 0.3× 110 1.2× 23 0.5× 28 744
Jiann‐Jyh Huang Taiwan 14 342 0.9× 266 1.0× 43 0.3× 75 0.8× 41 0.9× 26 618
Masaichi Hasegawa Japan 10 262 0.7× 326 1.2× 178 1.1× 65 0.7× 65 1.4× 17 681
Yongzhi Lu China 15 344 0.9× 192 0.7× 58 0.4× 128 1.4× 45 1.0× 34 765
Seigo Ishibuchi Japan 10 175 0.5× 166 0.6× 81 0.5× 30 0.3× 27 0.6× 14 370
Lijia Chen China 15 527 1.4× 132 0.5× 64 0.4× 153 1.6× 12 0.3× 53 831
Qianbin Li China 18 467 1.3× 295 1.1× 37 0.2× 157 1.7× 10 0.2× 66 886
Steven J. Woodhead United Kingdom 13 534 1.4× 263 1.0× 28 0.2× 167 1.8× 16 0.3× 19 889
Sandra K. Wittmann Germany 15 219 0.6× 74 0.3× 86 0.5× 60 0.6× 4 0.1× 22 603
Harilal Patel India 13 202 0.5× 67 0.3× 40 0.3× 75 0.8× 8 0.2× 46 512

Countries citing papers authored by Ritu Ojha

Since Specialization
Citations

This map shows the geographic impact of Ritu Ojha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ritu Ojha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ritu Ojha more than expected).

Fields of papers citing papers by Ritu Ojha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ritu Ojha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ritu Ojha. The network helps show where Ritu Ojha may publish in the future.

Co-authorship network of co-authors of Ritu Ojha

This figure shows the co-authorship network connecting the top 25 collaborators of Ritu Ojha. A scholar is included among the top collaborators of Ritu Ojha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ritu Ojha. Ritu Ojha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ojha, Ritu, I‐Chung Chen, Chien‐Ming Hsieh, et al.. (2021). Installation of Pargyline, a LSD1 Inhibitor, in the HDAC Inhibitory Template Culminated in the Identification of a Tractable Antiprostate Cancer Agent. Journal of Medicinal Chemistry. 64(24). 17824–17845. 25 indexed citations
2.
Ojha, Ritu, Kunal Nepali, Chun‐Han Chen, et al.. (2020). Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo. European Journal of Medicinal Chemistry. 190. 112086–112086. 35 indexed citations
3.
Thakur, Amandeep, Arshdeep Singh, Navdeep Kaur, Ritu Ojha, & Kunal Nepali. (2019). Steering the antitumor drug discovery campaign towards structurally diverse indolines. Bioorganic Chemistry. 94. 103436–103436. 40 indexed citations
4.
Lai, Mei-Jung, Ritu Ojha, Mei-Hsiang Lin, et al.. (2018). 1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase. European Journal of Medicinal Chemistry. 162. 612–630. 37 indexed citations
5.
Ojha, Ritu, Han-Li Huang, Wei‐Chun HuangFu, et al.. (2018). 1-Aroylindoline-hydroxamic acids as anticancer agents, inhibitors of HSP90 and HDAC. European Journal of Medicinal Chemistry. 150. 667–677. 48 indexed citations
6.
Ojha, Ritu, et al.. (2016). A survey on oral hygiene methods practiced by patients attending Dentistry Department at a Tertiary Care Hospital from Central Gujarat. Journal of International Society of Preventive and Community Dentistry. 6(2). 115–115. 9 indexed citations
7.
Nepali, Kunal, Ritu Ojha, Hsueh‐Yun Lee, & Jing‐Ping Liou. (2016). Early investigational tubulin inhibitors as novel cancer therapeutics. Expert Opinion on Investigational Drugs. 25(8). 917–936. 32 indexed citations
8.
Sharma, Sahil, Ritu Ojha, Harbinder Singh, et al.. (2016). Design strategies, structure activity relationship and mechanistic insights for purines as kinase inhibitors. European Journal of Medicinal Chemistry. 112. 298–346. 57 indexed citations
9.
Nepali, Kunal, et al.. (2016). Ring-opened tetrahydro-γ-carbolines display cytotoxicity and selectivity with histone deacetylase isoforms. European Journal of Medicinal Chemistry. 127. 115–127. 21 indexed citations
10.
Ojha, Ritu, et al.. (2016). An updated patent review: xanthine oxidase inhibitors for the treatment of hyperuricemia and gout (2011-2015). Expert Opinion on Therapeutic Patents. 27(3). 311–345. 78 indexed citations
11.
Singh, Harbinder, Sahil Sharma, Ritu Ojha, et al.. (2014). Synthesis and evaluation of naphthoflavones as a new class of non purine xanthine oxidase inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(17). 4192–4197. 50 indexed citations
12.
Nepali, Kunal, Ritu Ojha, Sahil Sharma, Preet Mohinder Singh Bedi, & Kanaya Lal Dhar. (2014). Tubulin Inhibitors: A Patent Survey. Recent Patents on Anti-Cancer Drug Discovery. 9(2). 176–220. 32 indexed citations
13.
14.
Ojha, Ritu, et al.. (2014). Preparation, Characterization and Optimization of Poloxamer Solid Dispersions of a Poorly Water Soluble Drug Aprepitant. British Journal of Pharmaceutical Research. 4(20). 2436–2454. 5 indexed citations
15.
Kumar, Dinesh, et al.. (2014). 4,6‐Diaryl/heteroarylpyrimidin‐2(1H)‐ones as a New Class of Xanthine Oxidase Inhibitors. Archiv der Pharmazie. 347(7). 486–495. 26 indexed citations
16.
Sharma, Sahil, Kirti Sharma, Ritu Ojha, et al.. (2013). Microwave assisted synthesis of naphthopyrans catalysed by silica supported fluoroboric acid as a new class of non purine xanthine oxidase inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(2). 495–500. 46 indexed citations
17.
Nepali, Kunal, et al.. (2013). Design, Synthesis and Evaluation of Arylidene Pyrrolo and Pyrido Fused Quinazolones as Antimicrobial Agents. Letters in Drug Design & Discovery. 10(6). 522–528. 6 indexed citations
18.
Patil, Sandeep B., Ritu Ojha, Gurpreet Kaur, et al.. (2013). Estimation of Seasonal Variation of Two Major Pyrrolo [2,1-b] Quinazoline Alkaloids of Adhatoda vasica by HPLC. The Natural Products Journal. 3(1). 30–34. 6 indexed citations
19.
Sharma, Sahil, Vikas Thakur, Ritu Ojha, et al.. (2013). Aza Analogs of Flavones as Potential Antimicrobial Agents. Letters in Drug Design & Discovery. 10(4). 327–334. 4 indexed citations
20.
Ojha, Ritu, et al.. (2012). Synthesis, In Vitro Hydrolysis, Bioanalytical Method Development and Pharmacokinetic Study of an Amide Prodrug of Ibuprofen. Current Pharmaceutical Analysis. 8(3). 261–271. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samir Mehndiratta Breakdown of academic impact, for papers by Jiann‐Jyh Huang Breakdown of academic impact, for papers by Masaichi Hasegawa Breakdown of academic impact, for papers by Yongzhi Lu Breakdown of academic impact, for papers by Seigo Ishibuchi Breakdown of academic impact, for papers by Lijia Chen Breakdown of academic impact, for papers by Qianbin Li Breakdown of academic impact, for papers by Steven J. Woodhead Breakdown of academic impact, for papers by Sandra K. Wittmann Breakdown of academic impact, for papers by Harilal Patel
Rankless by CCL
2026